| Pharmaceutical active ingredients: |
| Metronidazole BenzoateOfloxacin |
| Available forms, composition and doses of Okaflox M: |
| Suspension; Oral; Metronidazole Benzoate 100 mg; Ofloxacin 50 mg / 5 ml |
| Okaflox M medical category: |
| Human:AntiamoebicsAntibioticsQuinolonesTopical chemotherapeutics used in the treatment of dermatological diseases |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01MA01 - OfloxacinJ01XD01 - Metronidazole |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cipla |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nistazol | Metronidazole Benzoate; Nystatin | Hebron Industria Quimica e Farmaceutica |
| C-Flox-M | Metronidazole Benzoate; Ofloxacin | Corona Remedies |
| Ofacin-M | Metronidazole Benzoate; Ofloxacin | Medizone |
| Oflo-M | Metronidazole Benzoate; Ofloxacin | Nordic Formulations |
| OF-M | Metronidazole Benzoate; Ofloxacin | J.B. Chemicals & Pharmaceuticals |
| Olife-M | Metronidazole Benzoate; Ofloxacin | Lifeline Biotech |
| Oxo-M | Metronidazole Benzoate; Ofloxacin | Ind-Swift |
| Flagyl I.V. | Metronidazole Hydrochloride | Sanofi-Aventis; GD Searle |
| Hemestal | Metronidazole Hydrogen Succinate | Silanes Laboratorios |
| Aristogyl | Metronidazole; Metronidazole Benzoate | Aristo Pharmaceuticals |